Percutaneous options for heart failure in adults with congenital heart disease

Heart Fail Clin. 2014 Jan;10(1):179-96. doi: 10.1016/j.hfc.2013.09.018.

Abstract

In the context of congenital heart disease (CHD), the complex biochemical and physiologic response to the pressure- or volume-loaded ventricle can be induced by stenotic and shunt/regurgitant lesions, respectively. A range of transcatheter therapies have recently emerged to expand the therapeutic potential of the more traditional surgical and medical interventions for heart failure in patients with CHD. Together, these complementary interventions aim to treat the growing patient population with adult CHD (ACHD). In this article, the most commonly used transcatheter interventions for heart failure in patients with ACHD are reviewed.

Keywords: Adult congenital heart disease; Heart failure; Percutaneous intervention; Transcatheter intervention.

Publication types

  • Review

MeSH terms

  • Adult
  • Cardiac Catheterization* / adverse effects
  • Cardiac Catheterization* / instrumentation
  • Cardiac Catheterization* / methods
  • Dilatation, Pathologic / etiology
  • Heart Defects, Congenital / classification
  • Heart Defects, Congenital / complications
  • Heart Defects, Congenital / physiopathology
  • Heart Defects, Congenital / therapy*
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart Ventricles / pathology
  • Heart Ventricles / physiopathology
  • Humans
  • Outcome and Process Assessment, Health Care
  • Postoperative Complications* / classification
  • Postoperative Complications* / etiology
  • Ventricular Dysfunction / diagnosis
  • Ventricular Dysfunction / etiology
  • Ventricular Dysfunction / physiopathology
  • Ventricular Dysfunction / therapy*